2014 BRFSS Asthma Call-Back Survey Prevalence Tables
TABLE 10. Estimated percent using inhaled short acting beta agonists among adults1 with current2 or active3 asthma status by state/territory – BRFSS Asthma Call-back Survey Land Line Sample, United States, 2014
| State/Territory | Current | Active | ||||||
|---|---|---|---|---|---|---|---|---|
| Sample size± |
% | SE§ | 95% CI† | Sample size |
% | SE | 95% CI | |
| Alabama | 213 | 48.1 | 8.5 | (31.4 – 64.8) | 228 | 47.1 | 8.0 | (31.4 – 62.8) |
| Florida | 214 | 51.3 | 6.3 | (39.0 – 63.6) | 229 | 50.5 | 6.3 | (38.2 – 62.8) |
| Kansas | 264 | 50.2 | 6.4 | (37.7 – 62.7) | 278 | 50.3 | 6.3 | (38.0 – 62.6) |
| Louisiana | 93 | 68.2 | 9.1 | (50.4 – 86.0) | 106 | 57.0 | 10.5 | (36.4 – 77.6) |
| Massachusetts | 139 | 62.1 | 7.8 | (46.8 – 77.4) | 141 | 63.0 | 7.7 | (47.9 – 78.1) |
| 5 state total | 923 | 54.6 | 3.8 | (47.2 – 62.0) | 982 | 53.3 | 3.8 | (45.9 – 60.7) |
| Median | 51.3 | 50.5 | ||||||
| Range | 48.1-68.2 | 47.1-63.0 | ||||||
1 Aged ≥ 18 years
2 “Yes” response to “Do you still have asthma?”
3 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
± Landline sample size excludes “DK/Refused”
§ Standard error
† Confidence interval
Page last reviewed: February 14, 2017